< Back to previous page
Researcher
Annelii Ny
- Disciplines:Biomarker discovery and evaluation, Drug discovery and development, Medicinal products, Pharmaceutics, Pharmacognosy and phytochemistry, Pharmacology, Pharmacotherapy, Toxicology and toxinology, Other pharmaceutical sciences
Affiliations
- Molecular Biodiscovery (Division)
Member
From1 Apr 2013 → Today
Projects
1 - 7 of 7
- Open-source robotics-assisted synthesis of libraries of SF-bond containing compounds for medicinal chemistry applicationsFrom1 Oct 2024 → TodayFunding: IOF - technology concept exploration
- VITAL: Valuable Ingredients for Thriving Aging derived from ligninFrom1 Oct 2024 → TodayFunding: Fund Recuperation Fiscal Exemption, IOF - technology validation in lab
- Building towards a patent - Exploitation of the killifish R&D platform to combat neurodegenerative diseasesFrom1 Feb 2024 → 31 Jan 2025Funding: IOF - mandates
- PHGDH-ASM: Phosphoglycerate dehydrogenase (PHGDH) activators as novel antiseizure medications (ASM) with dual mode of actionFrom1 Oct 2022 → 30 Sep 2024Funding: IOF - technology validation in lab
- Zebrafish platform for neuroactive drug discovery and safety assessmentFrom1 Jan 2019 → 31 Dec 2020Funding: IOF - technology validation in lab
- Use of fluorescent probes to study pharmacokinetics in zebrafish (Danio rerio) embryos and larvaeFrom12 Dec 2017 → 19 Nov 2021Funding: Own budget, for example: patrimony, inscription fees, gifts
- Aquatic platform for drug discovery and safety testingFrom1 Jan 2016 → TodayFunding: IOF - Industrial Research Fund, IOF - mandates
Publications
1 - 10 of 25
- Clioquinol as a new therapy in epilepsy: From preclinical evidence to a proof-of-concept clinical study.(2025)Published in: EPILEPSIAISSN: 0013-9580Issue: 10Volume: 66
- ELFN1 deficiency: The mechanistic basis and phenotypic spectrum of a neurodevelopmental disorder with epilepsy(2025)Published in: Genetics in MedicineISSN: 1098-3600Issue: 9Volume: 27
- Assessment of receptor-mediated activity (AhR and ERα), mutagenicity, and teratogenicity of metal shredder wastes in Wallonia, Belgium.(2024)Published in: Environmental Science and Pollution ResearchISSN: 0944-1344Issue: 43Volume: 31Pages: 55263 - 55279
- Use of fluorescent probes to study pharmacokinetics in zebrafish (Danio rerio) embryos and larvae(2021)
- Pre-validation of choriogenin H transgenic medaka eleutheroembryos as a quantitative estrogenic activity test method(2021)Published in: Analytical BiochemistryISSN: 0003-2697Volume: 629
- Spatiotemporal imaging and pharmacokinetics of fluorescent compounds in zebrafish eleuthero-embryos after different routes of administration(2021)Published in: Scientific ReportsISSN: 2045-2322Issue: 1Volume: 11
- Infection of zebrafish larvae with human norovirus and evaluation of the in vivo efficacy of small-molecule inhibitors(2021)Published in: Nature ProtocolsISSN: 1754-2189Issue: 4Volume: 16Pages: 1830 - +
- Nephrotoxic Effects in Zebrafish after Prolonged Exposure to Aristolochic Acid(2020)Published in: ToxinsISSN: 2072-6651Issue: 4Volume: 12
- A robust human norovirus replication model in zebrafish larvae(2019)Published in: PLoS PathogensISSN: 1553-7366Issue: 9Volume: 15
- Safety Assessment of Compounds after In Vitro Metabolic Conversion Using Zebrafish Eleuthero Embryos(2019)Published in: International Journal of Molecular SciencesISSN: 1661-6596Issue: 7Volume: 20
Patents
1 - 9 of 9
- Alkylated haloquinolines for use in epilepsy
- Treatment for epilepsy
- Treatment of pharmacoresistant epilepsy
- Idebenone in the treatment of drug resistant epilepsy
- Treatment of epilepsy
- Treatment of epilepsy with plinabulin or halimide or diketopiperazine derivatives
- Treatment of epilepsy with plinabulin or halimide or diketopiperazine derivatives
- Treatment of epilepsy
- Treatment of epilepsy